>DEF 14A

Company

Protagonist Therapeutics, Inc

Filed

April 18, 2018

Period of Report

May 29, 2018

Accession Number

0001047469-18-002924

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →